TOKYO, May 14 (Pulse News Wire) – HEALIOS K.K. (4593.T) reported its financial results for the first quarter of the fiscal year ending December 2026, covering the period from January 1, 2026, to March 31, 2026.
For the quarter, the company recorded financial income of ¥326 million. Key components included securities valuation gains of ¥260 million, profit and loss transfers related to external investors' shares in the Saisei Fund of ¥48 million, and interest received amounting to ¥16 million.
Additionally, the company recognized financial expenses totaling ¥2.659 billion, primarily due to derivative evaluation losses of ¥2.573 billion and issuance costs associated with subscription rights of ¥71 million. The impact of these financial items on the overall performance is detailed in the interim report released today titled “Interim Report for the First Quarter Ending December 2026 (Consolidated IFRS).” HEALIOS CEO Masanori Kajimoto stated that the financial outcomes reflect the company’s ongoing efforts to optimize its investment portfolio and manage financial risks effectively.
CFO Richard Kincaid emphasized the importance of adhering to international accounting standards while ensuring transparency in financial reporting.
🟢 Confidence: High AI-translated content.